Sweden· SE-20171027000015
GHRYVELIN 60 mg Granulat till oral suspension i dospåse
A medicinal product containing macimorelin, registered in Sweden by Atnahs Pharma Netherlands B.V..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Macimorelin
- Manufacturer
- Atnahs Pharma Netherlands B.V.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20171027000015
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Macimorelin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomGhryvelin 60mg granules for oral suspension sachetsConsilient Health Ltd
- CzechiaGHRYVELINAtnahs Pharma Netherlands B.V., Amsterdam
- BelgiumGhryvelin 60 mgAtnahs Pharma Netherlands
- IcelandGHRYVELINAtnahs Pharma Netherlands B.V.
- NetherlandsGHRYVELIN 60 mg granulaat voor orale suspensie in sachetAtnahs Pharma Netherlands B.V.
- NorwayGhryvelinAtnahs Pharma Netherlands B.V.
- IrelandGHRYVELIN 60 mg granules for oral suspension in sachetAtnahs Pharma Netherlands B.V.
- United StatesMacrilenNovo Nordisk
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- United Kingdom (Northern Ireland) · Macimorelin Atnahs Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9c9aa27f-b564-4bb4-9eac-dbd91c1b1653 GET /v1/drugs/9c9aa27f-b564-4bb4-9eac-dbd91c1b1653?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20171027000015",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20171027000015",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/ghryvelin"
}See everything about macimorelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.